Clinics Delivery across UAE
Peptide Therapy

Weight Management & Metabolic

Transform your metabolism.

5 peptides in this category

Prescription & blood work required
Pharma Grade3ml vial

The Fat-Burning Fragment

AOD-9604 3.6mg

Lipolytic HGH fragment — targeted fat loss without diabetogenic effects

Contact for pricing

Clinical Uses

  • Stubborn body fat reduction
  • Visceral and subcutaneous fat loss
  • Metabolic syndrome support
  • Weight-loss plateau breaking
  • Post-weight-loss composition refinement

Key Benefits

  • Directly stimulates fat cell breakdown
  • Does NOT raise blood sugar (unlike hGH)
  • Does NOT suppress natural GH production
  • Safe for long-term use
  • No water retention or insulin resistance

How It Works

AOD-9604 binds beta-3 adrenergic receptors on adipocytes, raising cAMP and activating hormone-sensitive lipase to break down triglycerides while inhibiting lipogenesis.

Dosage: 300–500 mcg subcutaneous injection daily, morning fasted. Cycle 3 months on, 1 month off.
Results: Weeks 2–4: reduced waist circumference. Months 2–3: visible fat loss. Month 3: compositional remodelling.
Pharma Grade3ml vial

High-Dose AOD

AOD-9604 15mg

High-dose AOD-9604 — advanced metabolic fat-burning protocol

Contact for pricing

Clinical Uses

  • Advanced fat-loss protocols
  • Extended metabolic optimisation
  • Recomposition goals

Key Benefits

  • Larger vial for uninterrupted 12-week protocols
  • Same safe lipolytic mechanism
  • Cost-efficient for longer cycles

How It Works

Same AOD-9604 fragment mechanism at higher concentration to support extended, uninterrupted fat-loss protocol continuity.

Dosage: 300–500 mcg subcutaneous daily. 15mg vial covers ~30–50 doses.
Results: Same 90-day timeline as the 3.6mg protocol, with protocol continuity.
Pharma Grade3ml vial

Mitochondrial Metabolism

MOTS-C 30mg

Mitochondrial-derived peptide — metabolic flexibility and insulin sensitivity

Contact for pricing

Clinical Uses

  • Metabolic syndrome and insulin resistance
  • Type 2 diabetes support
  • Obesity and visceral fat
  • Exercise performance enhancement
  • Mitochondrial dysfunction and fatigue

Key Benefits

  • Activates AMPK master metabolic enzyme
  • Exercise-mimetic metabolic effects
  • Improves insulin sensitivity safely
  • Reduces visceral fat, preserves lean mass
  • Mitochondrially encoded — unique mechanism

How It Works

MOTS-c activates AMPK and regulates glucose and fatty acid metabolism, increasing GLUT4 translocation, activating PGC-1α and improving whole-body insulin sensitivity.

Dosage: 5–10 mg subcutaneous 3–5x per week, morning before exercise. 8–12 weeks.
Results: Week 1–2: improved energy. Weeks 2–4: fasting glucose gains. Weeks 8–12: panel normalisation.
Pharma Grade3ml vial

Triple GLP Agonist

Fat Burn Plus 15mg

Triple GLP-1 agonist stack — appetite control and weight management

Contact for pricing

Clinical Uses

  • Medical weight loss and obesity
  • Type 2 diabetes management
  • Metabolic syndrome
  • Cardiovascular risk reduction in obesity
  • NAFLD support

Key Benefits

  • Triple GLP-1/GIP/glucagon activity
  • Reduces appetite centrally
  • Improves glycemic control and HbA1c
  • Reduces visceral and hepatic fat
  • Cardiovascular protection

How It Works

Fat Burn Plus targets GLP-1, GIP and glucagon receptors: GLP-1R reduces appetite and slows gastric emptying; GIP-R enhances insulin and fat metabolism; glucagon-R raises energy expenditure.

Dosage: Start 2.5 mg weekly subcutaneous for 4 weeks, escalate to 5 mg then 10 mg at month 2–3. Same day weekly.
Results: Weeks 1–4: reduced appetite. Weeks 4–16: 8–12% weight loss. Weeks 16–24: 15–20%+.
Pharma Grade3ml vial

Maximum GLP-1

Fat Burn Plus 40mg

High-dose Fat Burn Plus — maximum activity for significant weight loss

Contact for pricing

Clinical Uses

  • Advanced medical weight loss
  • Type 2 diabetes with significant obesity
  • Extended weight management protocol

Key Benefits

  • 40mg vial for extended treatment
  • Outperforms semaglutide and tirzepatide
  • Sustained 15–25% weight loss
  • Cardiovascular and hepatic protection

How It Works

Same Fat Burn Plus triple-agonist mechanism; 40mg vial supports 3–4 months of weekly escalating dosing up to maximum therapeutic dose.

Dosage: Same escalation: 2.5 → 5 → 10 → 15–20 mg weekly. 40mg vial ~8–16 weekly doses.
Results: Weeks 4–16 progressive loss; weeks 16–24 up to 20%+ total reduction.
All categories

Confirm your eligibility

Start with a mandatory blood panel and physician consultation before any peptide protocol.

Book a consultation